Ar­ray joins Pfiz­er on an­ti-can­cer com­bos, the lat­est in a string of binime­tinib com­bi­na­tions

Pfiz­er $PFE has struck a deal with Boul­der-based Ar­ray Bio­Phar­ma $AR­RY to fund clin­i­cal tri­als in­volv­ing sev­er­al an­ti-can­cer com­bi­na­tions from both drug­mak­ers.

The plan is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER